Skip to main content
ELV logo

ELV · Elevance Health, Inc. · Analyst Estimates

Track ELV — free
$388.82 -3.91 (-1.00%) At close · Sep 30
Market Cap
$85.90B
Shares
216.87M
Volume · Sep 30 1.3M Avg daily vol (3M) 1.25M

Analyst Estimates

Compare analyst forecasts for Elevance Health, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-26 08:04 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
26.99619
27.1665
28.25
—
27.16015
27.15838
27.1665
26.90299
— — — —
EPS
analysts
Publication date not stated
— — —
22
— — — —
1
1
0
0
Revenue
USD
Publication date not stated
192660507650
196597849440
200918000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
13
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
29.0
29.53956
31.0
—
29.60546
29.63423
29.53956
29.2475
— — — —
EPS
analysts
Publication date not stated
— — —
22
— — — —
0
0
2
1
Revenue
USD
Publication date not stated
193083000000
200325004100
209253000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
13
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
4.55
4.66126
4.99
—
4.66488
4.67141
4.66495
5.09701
— — — —
EPS
analysts
Publication date not stated
— — —
19
— — — —
14
14
3
3
Revenue
USD
Publication date not stated
48371000000
49121932460
50189500000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
11
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
1.91
2.43011
3.31
—
2.46811
2.48509
2.46811
2.99769
— — — —
EPS
analysts
Publication date not stated
— — —
20
— — — —
1
1
0
0
Revenue
USD
Publication date not stated
46554000000
48121109030
49747000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
11
— — — — — — — —
Key facts CIK 1156039 CUSIP 036752103 13F (30d) 53 filings 21 filers Visit website Investor relations